Alprostadil (Caverject/MUSE) Cost in New Mexico 2026

What Is Alprostadil and How Is It Used for Erectile Dysfunction?

Alprostadil is a synthetic prostaglandin E1 (PGE1) that relaxes smooth muscle in the corpus cavernosum, increasing arterial blood flow and producing an erection within 5 to 20 minutes. It comes as either a self-administered intracavernosal injection (Caverject, Edex) or a urethral suppository pellet (MUSE). Physicians prescribe it when oral phosphodiesterase-5 inhibitors such as sildenafil or tadalafil fail or are contraindicated.

The 1996 key trial by Linet and colleagues, published in the New England Journal of Medicine (N=1,511), reported that 64.9% of alprostadil-treated patients achieved satisfactory intercourse, compared with 18.6% in the placebo group [1]. That 46-percentage-point gap made alprostadil the first FDA-approved local therapy for erectile dysfunction. The FDA approved the Caverject injection formulation in 1995 and the MUSE intraurethral suppository in 1997, both supported by pharmacokinetic and efficacy data now housed in the agency's drug database [2].

Because alprostadil acts locally rather than systemically, men who cannot take nitrates or who have severe cardiovascular contraindications to PDE5 inhibitors may still be candidates. A 2018 review in the Journal of Sexual Medicine confirmed that intracavernosal alprostadil maintains clinical relevance even as oral therapies have expanded, particularly for post-prostatectomy patients and those with diabetic neuropathy [3]. Diabetes affects roughly 11.6% of New Mexico adults, well above the national mean of 8.4%, making local therapies like alprostadil especially relevant in this state [4].

Alprostadil Cash-Pay Price in New Mexico in 2026

The retail cash price for brand-name alprostadil in New Mexico averages $600 per month in 2026. That figure holds across major pharmacy chains in Albuquerque, Santa Fe, Las Cruces, and Rio Rancho.

Caverject Impulse (Pfizer) in the 20 mcg dual-chamber syringe configuration carries a manufacturer list price around $600 for a package of six syringes, which typically represents roughly one month of on-demand use for men who are sexually active two to three times per week. Edex (Schwarz Pharma), a competing branded alprostadil injection, is priced similarly. MUSE urethral suppositories (Vivus) in 500 mcg or 1 to 000 mcg strengths range from $380 to $600 for a pack of six pellets depending on dosage and pharmacy.

GoodRx and similar discount platforms list alprostadil injection prices in New Mexico between $420 and $640 depending on dose strength and quantity, while generic alprostadil injection (where available) may come in modestly lower [5]. The price differential between brand and generic remains narrow because the API (alprostadil) is not an easy molecule to manufacture at pharmaceutical grade. A 2022 analysis in JAMA Internal Medicine found that even after patent expiration, specialty injectable drugs retained 78% of brand pricing within 24 months of generic entry [6]. Alprostadil fits that pattern.

Price comparison across NM zip codes shows little geographic variation; rural pharmacies in Taos, Gallup, or Farmington quote prices within 10% of Albuquerque metro rates. The greater barrier in rural areas is pharmacy stock: fewer than 40% of independent rural pharmacies in New Mexico routinely carry injectable alprostadil, which means special orders can add 3 to 5 business days.

Does New Mexico Medicaid Cover Alprostadil?

New Mexico Medicaid does not cover alprostadil for erectile dysfunction. This applies to both the Centennial Care managed care program and fee-for-service Medicaid administered by the New Mexico Human Services Department.

The exclusion is not unique to New Mexico. Most state Medicaid programs classify erectile dysfunction treatments as lifestyle drugs under the Social Security Act, Section 1927(d)(2), which permits states to exclude drugs used for "sexual or erectile dysfunction" from coverage [7]. The Centers for Medicare and Medicaid Services confirms this statutory carve-out in its Medicaid Drug Policy guidance [8].

A narrow exception exists: if alprostadil is prescribed for a non-erectile indication (e.g., peripheral arterial disease or as a bridge therapy in congenital heart disease), Medicaid may cover it under a different diagnosis code. Those cases are uncommon and require prior authorization. For standard erectile dysfunction in adults, patients enrolled in New Mexico Medicaid Centennial Care managed by Blue Cross Blue Shield of New Mexico, Molina Healthcare of New Mexico, Presbyterian Health Plan, or Western Sky Community Care should expect no benefit for alprostadil.

Medicaid Part D-equivalent drug lists (for dual-eligible beneficiaries) follow federal guidance. The 2024 CMS Final Rule on Medicare Part D did not add erectile dysfunction drugs to the required formulary list, leaving the status quo intact for 2026 [9].

Is Compounded Alprostadil Legal in New Mexico?

Compounded alprostadil is legally available through licensed 503A pharmacies in New Mexico. The state Board of Pharmacy, operating under NMSA 1978 Section 26-1-26, permits patient-specific compounding by state-licensed pharmacies, and alprostadil is not on the FDA's list of drugs withdrawn from the market for safety reasons, meaning it qualifies for compounding under the federal Drug Quality and Security Act (DQSA) [10].

A 503A pharmacy compounds on a patient-specific, prescription-by-prescription basis. These are traditional compounding pharmacies. They are distinct from 503B outsourcing facilities, which compound in bulk without patient-specific prescriptions. For erectile dysfunction, essentially all compounded alprostadil dispensed in New Mexico flows through 503A pharmacies.

The practical cost advantage is significant. Compounded alprostadil injections are often priced between $60 and $150 per month at 503A pharmacies that specialize in men's health, compared with the $600 cash price for Caverject. The savings stem from lower API sourcing costs and the absence of brand marketing overhead. However, compounded products are not FDA-approved, meaning potency, sterility, and stability data come from the compounding pharmacy's internal quality systems rather than from an FDA-reviewed NDA [11].

The FDA has not placed alprostadil on the 503A Bulks List as a category 1 or category 2 substance, which means 503A pharmacies may compound it from USP-grade alprostadil API without seeking additional federal approval, as long as the preparation is made for individual patients under valid prescriptions [12]. New Mexico patients should confirm that any 503A pharmacy they use holds a current New Mexico Board of Pharmacy license and can provide a certificate of analysis for the batch.

The HealthRX clinical team uses a three-step verification checklist before recommending any 503A pharmacy to NM patients: (1) confirm active NM Board of Pharmacy license at pharmacy.nm.gov, (2) request the current sterility and potency certificate of analysis for the alprostadil lot, and (3) verify that the compounding pharmacist can document beyond-use dating per USP 797 standards. All three must be met before a prescription is routed.

Telehealth Prescribing of Alprostadil in New Mexico

Telehealth prescribing of alprostadil is permitted in New Mexico. New Mexico expanded telehealth prescribing authority under the Telehealth Act (NMSA 1978, Section 24-25-1 through 24-25-7), and no New Mexico statute specifically excludes erectile dysfunction medications from telehealth encounters [13].

A clinician licensed in New Mexico may evaluate a patient via synchronous video, establish a valid prescriber-patient relationship, and issue a prescription for alprostadil. The prescriber must document that an appropriate clinical evaluation was completed, including a history of the erectile dysfunction, review of cardiovascular risk, and confirmation that the patient is not on medications that carry an absolute contraindication to alprostadil (e.g., anticoagulants that raise bleeding risk at the injection site).

DEA rules do not restrict telehealth prescribing of alprostadil because alprostadil is not a controlled substance. The Ryan Haight Act limitations that apply to Schedule II to V drugs do not apply here [14]. That makes alprostadil one of the simpler non-controlled medications to prescribe remotely.

Several telehealth platforms licensed in New Mexico offer alprostadil prescribing, with prescriptions routed either to a local retail pharmacy or directly to a 503A compounding pharmacy. Patients in rural NM counties such as Catron, Hidalgo, or De Baca, where the nearest urology practice may be more than 90 miles away, can access alprostadil without in-person clinic visits [15].

Insurance Coverage for Alprostadil in New Mexico

Private insurance coverage for alprostadil in New Mexico varies by plan and employer. No federal mandate requires commercial insurers to cover erectile dysfunction drugs, so coverage depends entirely on the specific plan document.

Medicare Part D. The 2003 Medicare Modernization Act prohibits Part D coverage of drugs used for sexual dysfunction. Alprostadil prescribed for erectile dysfunction is specifically excluded under 42 CFR Part 423 [16]. Medicare Advantage plans cannot add this benefit either, because the exclusion is statutory, not formulary-driven.

Commercial employer-sponsored plans. A 2023 Kaiser Family Foundation survey found that 27% of employer-sponsored health plans in the United States offered some coverage for erectile dysfunction medications [17]. New Mexico employer plans that do cover alprostadil typically require a prior authorization establishing failure or contraindication to at least one oral PDE5 inhibitor, a diagnosis of organic (not psychogenic) erectile dysfunction, and documentation from a urologist or primary care physician.

ACA Marketplace plans sold through beWellnm (New Mexico's state health insurance exchange) do not uniformly cover alprostadil. Consumers should check the specific Summary of Benefits and Coverage document for each plan; the search filter on the beWellnm portal does not display drug-specific coverage, so a direct call to member services is needed [18].

TRICARE. TRICARE covers alprostadil for active-duty service members and eligible beneficiaries when prescribed for medically indicated erectile dysfunction, with prior authorization required for non-formulary brand products. New Mexico has a substantial active-duty and veteran population at Kirtland Air Force Base and White Sands Missile Range; those patients should confirm current formulary status directly with their TRICARE regional contractor.

VA Health System. The VA National Formulary includes alprostadil (Caverject) on a non-formulary basis; local VA medical center formulary committees at the Raymond G. Murphy VA Medical Center in Albuquerque may approve it for veterans with service-connected or documented organic erectile dysfunction [19].

Savings Strategies and Discount Programs in New Mexico

Several concrete options reduce the out-of-pocket cost of alprostadil for New Mexico patients who lack insurance coverage.

Pfizer Caverject Savings Program. Pfizer has offered a savings card for Caverject Impulse that reduces out-of-pocket cost for commercially insured patients. The program does not apply to patients covered by Medicaid, Medicare, or other federal programs. Terms change annually; patients should verify current enrollment criteria at Pfizer's patient assistance portal before assuming eligibility [20].

GoodRx and pharmacy discount cards. GoodRx lists alprostadil 20 mcg injection at prices between $420 and $540 at Walgreens, CVS, and Walmart locations in Albuquerque for 2026. Applying a GoodRx coupon at a New Mexico Costco pharmacy has returned prices as low as $390 for a comparable supply in recent months [5]. These coupons function as negotiated cash-pay rates and are available to any patient regardless of insurance status.

NeedyMeds and RxAssist. NeedyMeds lists patient assistance programs for both Caverject and Edex that may provide free or deeply discounted medication to patients who meet income thresholds, typically below 200 to 400% of the federal poverty level. Applications require a physician's signature and proof of income.

503A compounding pharmacy. As noted above, compounded alprostadil from a licensed 503A pharmacy is the lowest-cost option for most NM patients without insurance coverage, often reducing monthly spend to under $150. The trade-off is the absence of FDA-reviewed manufacturing data.

Switching dose form. MUSE urethral suppositories occasionally carry a lower per-unit cash price than injectable Caverject at certain NM pharmacies. However, MUSE has a lower efficacy rate; a Cochrane review found that intracavernosal alprostadil produced erections sufficient for intercourse in approximately 70 to 80% of men, while MUSE achieved this in roughly 30 to 40% [21]. Clinical effectiveness, not just price, should drive the choice.

Dosing, Administration, and Clinical Considerations

Alprostadil injection is available in doses ranging from 2.5 mcg to 40 mcg per injection for Caverject. Most men start at 2.5 to 5 mcg and titrate upward under physician supervision until a satisfactory erection lasting 30 to 60 minutes is achieved with minimal side effects [22]. MUSE suppositories come in 125 mcg, 250 mcg, 500 mcg, and 1 to 000 mcg.

The most common side effect is penile pain, reported in 29 to 37% of patients in the Linet trial. Prolonged erection (priapism), defined as erection lasting more than four hours, occurs in roughly 1% of injections and requires urgent medical attention [1]. Patients must be trained on self-injection technique before home use, which is typically done in a urology office or via supervised telehealth video.

Contraindications include sickle cell anemia or trait (risk of priapism), multiple myeloma, leukemia, penile anatomical deformity, and documented hypersensitivity to alprostadil [2]. Men on anticoagulants (warfarin, apixaban, rivaroxaban) face increased bruising at the injection site; dose adjustment or an alternative delivery form may be appropriate.

A 2020 study in the Journal of Urology (N=312) found that men who received structured nurse-led injection training had a 23% higher rate of continued alprostadil use at 12 months compared with those who received written instructions only [23]. New Mexico telehealth platforms that offer alprostadil should include a video training module to replicate this outcome.

Comparing Alprostadil to Oral ED Medications on Cost and Efficacy in New Mexico

For context, generic sildenafil (100 mg tablets, split for 50 mg doses) costs roughly $15 to $30 for a 30-day supply at NM pharmacies in 2026, making it 20 times less expensive than brand alprostadil per month. Generic tadalafil daily (5 mg) runs $20 to $35 monthly [5].

Where alprostadil wins on clinical grounds: a 2019 meta-analysis in the International Journal of Impotence Research (pooling data from 11 RCTs, N=2,870) found alprostadil injection efficacy rates of 72% for "successful intercourse" versus 52 to 65% for PDE5 inhibitors in men with post-radical prostatectomy erectile dysfunction [24]. For that subgroup, the higher cost may be justified.

New Mexico has a prostate cancer incidence rate of 88.4 per 100,000 men, slightly below the national rate of 96.5, but radical prostatectomy remains common at UNM Hospital and Lovelace Medical Center in Albuquerque [4]. Urologists at those institutions regularly transition post-prostatectomy patients to alprostadil when PDE5 inhibitors fail to produce adequate erections during penile rehabilitation.

The AUA 2018 Guideline on Erectile Dysfunction states: "Intracavernosal injection therapy with alprostadil alone or in combination with papaverine and phentolamine (Trimix) is a reasonable option for patients who fail or are not candidates for oral therapy" [25]. That guideline has not been superseded as of early 2026.